Prot #R668-AD-1314: A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults with Moderate to Severe Atopic Dermatitis Treated with Dupilumab

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date10/9/1410/9/17

    Funding

    • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1314)